{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:02:04Z","timestamp":1784286124937,"version":"3.55.0"},"reference-count":216,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001773","name":"University of New South Wales","doi-asserted-by":"publisher","award":["HIC2"],"award-info":[{"award-number":["HIC2"]}],"id":[{"id":"10.13039\/501100001773","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001773","name":"University of New South Wales","doi-asserted-by":"publisher","award":["ZNF410"],"award-info":[{"award-number":["ZNF410"]}],"id":[{"id":"10.13039\/501100001773","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006920","name":"University of Pennsylvania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK132286"],"award-info":[{"award-number":["R01DK132286"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35GM134744"],"award-info":[{"award-number":["R35GM134744"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"CPRIT","doi-asserted-by":"publisher","award":["RR160029"],"award-info":[{"award-number":["RR160029"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Biology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jmb.2023.168343","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T23:23:52Z","timestamp":1698967432000},"page":"168343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["C2H2 Zinc Finger Transcription Factors Associated with Hemoglobinopathies"],"prefix":"10.1016","volume":"436","author":[{"given":"Xing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9533-4761","authenticated-orcid":false,"given":"Xiaotian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0873-0724","authenticated-orcid":false,"given":"Robert M.","family":"Blumenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmb.2023.168343_b0005","first-page":"417","article-title":"Transcription factors: an overview","volume":"74","author":"Latchman","year":"1993","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.jmb.2023.168343_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100741","article-title":"How structural biology transformed studies of transcription regulation","volume":"296","author":"Wolberger","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2023.168343_b0015","doi-asserted-by":"crossref","first-page":"e1752","DOI":"10.1002\/wrna.1752","article-title":"Integrating transcription and splicing into cell fate: Transcription factors on the block","volume":"14","author":"Boumpas","year":"2023","journal-title":"Wiley Interdiscip Rev. RNA."},{"key":"10.1016\/j.jmb.2023.168343_b0020","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bcp.2017.06.122","article-title":"Transcription factor decoy technology: A therapeutic update","volume":"144","author":"Hecker","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jmb.2023.168343_b0025","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1016\/j.drudis.2021.07.018","article-title":"Drugging the 'undruggable'. Therapeutic targeting of protein-DNA interactions with the use of computer-aided drug discovery methods","volume":"26","author":"Radaeva","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jmb.2023.168343_b0030","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.molcel.2015.10.002","article-title":"Nucleosome stability distinguishes two different promoter types at all protein-coding genes in yeast","volume":"60","author":"Kubik","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jmb.2023.168343_b0035","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.sbi.2021.06.016","article-title":"Structural insights into the interaction between transcription factors and the nucleosome","volume":"71","author":"Morgunova","year":"2021","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.jmb.2023.168343_b0040","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.jmb.2019.09.013","article-title":"Detection of DNA modifications by sequence-specific transcription factors","volume":"432","author":"Yang","year":"2020","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2023.168343_b0045","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.jmb.2019.12.018","article-title":"DNA modification readers and writers and their interplay","volume":"432","author":"Rausch","year":"2020","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2023.168343_b0050","doi-asserted-by":"crossref","DOI":"10.1111\/nyas.15033","article-title":"Inheritance of epigenetic transcriptional memory through read-write replication of a histone modification","author":"Brickner","year":"2023","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jmb.2023.168343_b0055","doi-asserted-by":"crossref","DOI":"10.3390\/genes12101596","article-title":"The expanding constellation of histone post-translational modifications in the epigenetic landscape","volume":"12","author":"Cavalieri","year":"2021","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.jmb.2023.168343_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.sbi.2021.04.003","article-title":"Mechanistic similarities in recognition of histone tails and DNA by epigenetic readers","volume":"71","author":"Vann","year":"2021","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.jmb.2023.168343_b0065","doi-asserted-by":"crossref","first-page":"18795","DOI":"10.1038\/s41598-020-75711-4","article-title":"Specifically bound BZIP transcription factors modulate DNA supercoiling transitions","volume":"10","author":"Horberg","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jmb.2023.168343_b0070","doi-asserted-by":"crossref","first-page":"9280","DOI":"10.1093\/nar\/gkab691","article-title":"Sequence-specific dynamics of DNA response elements and their flanking sites regulate the recognition by AP-1 transcription factors","volume":"49","author":"Horberg","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmb.2023.168343_b0075","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1126\/science.1104935","article-title":"Mouse brain organization revealed through direct genome-scale TF expression analysis","volume":"306","author":"Gray","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jmb.2023.168343_b0080","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrg2538","article-title":"A census of human transcription factors: function, expression and evolution","volume":"10","author":"Vaquerizas","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jmb.2023.168343_b0085","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/160786a0","article-title":"Crystal structure of human carboxyhaemoglobin","volume":"160","author":"Perutz","year":"1947","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2023.168343_b0090","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1182\/blood-2008-04-078188","article-title":"Hemoglobin research and the origins of molecular medicine","volume":"112","author":"Schechter","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jmb.2023.168343_b0095","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1101\/gad.303461.117","article-title":"Comparative analysis of three-dimensional chromosomal architecture identifies a novel fetal hemoglobin regulatory element","volume":"31","author":"Huang","year":"2017","journal-title":"Genes Dev."},{"key":"10.1016\/j.jmb.2023.168343_b0100","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1073\/pnas.81.8.2416","article-title":"Embryonic\u2013\u2013Fetal Hb switch in humans: studies on erythroid bursts generated by embryonic progenitors from yolk sac and liver","volume":"81","author":"Peschle","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.jmb.2023.168343_b0105","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2141.2010.08105.x","article-title":"Advances in the understanding of haemoglobin switching","volume":"149","author":"Sankaran","year":"2010","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jmb.2023.168343_b0110","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/s41586-020-2292-y","article-title":"Origin of complexity in haemoglobin evolution","volume":"581","author":"Pillai","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2023.168343_b0115","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a011627","article-title":"Evolution of hemoglobin and its genes","volume":"2","author":"Hardison","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.jmb.2023.168343_b0120","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bcmd.2017.08.001","article-title":"Evolution of hemoglobin loci and their regulatory elements","volume":"70","author":"Philipsen","year":"2018","journal-title":"Blood Cell Mol. Dis."},{"key":"10.1016\/j.jmb.2023.168343_b0125","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12862-016-0597-0","article-title":"Convergent evolution of hemoglobin switching in jawed and jawless vertebrates","volume":"16","author":"Rohlfing","year":"2016","journal-title":"BMC Evol. Biol."},{"key":"10.1016\/j.jmb.2023.168343_b0130","first-page":"261","article-title":"A Cambrian origin for globin gene regulation","volume":"136","author":"Hardison","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jmb.2023.168343_b0135","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1101\/gr.6761107","article-title":"28-way vertebrate alignment and conservation track in the UCSC Genome Browser","volume":"17","author":"Miller","year":"2007","journal-title":"Genome Res."},{"key":"10.1016\/j.jmb.2023.168343_b0140","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nature14438","article-title":"The origin and early phylogenetic history of jawed vertebrates","volume":"520","author":"Brazeau","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2023.168343_b0145","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1001\/archinte.1910.00050330050003","article-title":"Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia","volume":"6","author":"Herrick","year":"1910","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.jmb.2023.168343_b0150","first-page":"443","article-title":"Sickle cell anemia, a molecular disease","volume":"109","author":"Pauling","year":"1949","journal-title":"Science"},{"key":"10.1016\/j.jmb.2023.168343_b0155","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/178792a0","article-title":"A specific chemical difference between the globins of normal human and sickle-cell anaemia haemoglobin","volume":"178","author":"Ingram","year":"1956","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2023.168343_b0160","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0022-2836(79)90170-0","article-title":"Crystallization of deoxyhemoglobin S by fiber alignment and fusion","volume":"135","author":"Wellems","year":"1979","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2023.168343_b0165","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1182\/blood.V58.6.1057.1057","article-title":"The intracellular polymerization of sickle hemoglobin and its relevance to sickle cell disease","volume":"58","author":"Noguchi","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.jmb.2023.168343_b0170","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/00000441-194804000-00008","article-title":"The significance of the paucity of sickle cells in newborn Negro infants","volume":"215","author":"Watson","year":"1948","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.jmb.2023.168343_b0175","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2141.1975.tb01813.x","article-title":"Hereditary persistence of fetal haemoglobin","volume":"29","author":"Weatherall","year":"1975","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jmb.2023.168343_b0180","first-page":"24","article-title":"Genetic disorders of hemoglobin","volume":"36","author":"Weatherall","year":"1999","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.jmb.2023.168343_b0185","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(72)92592-5","article-title":"Benign sickle-cell anaemia","volume":"2","author":"Perrine","year":"1972","journal-title":"Lancet"},{"key":"10.1016\/j.jmb.2023.168343_b0190","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S0140-6736(86)92205-1","article-title":"Sickle cell disease in Orissa State","volume":"2","author":"Kar","year":"1986","journal-title":"India. Lancet."},{"key":"10.1016\/j.jmb.2023.168343_b0195","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJM199107043250103","article-title":"Pain in sickle cell disease. Rates and risk factors","volume":"325","author":"Platt","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jmb.2023.168343_b0200","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1182\/blood.V84.2.643.643","article-title":"The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease","volume":"84","author":"Castro","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.jmb.2023.168343_b0205","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jmb.2023.168343_b0210","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood-2013-09-528067","article-title":"Fetal hemoglobin in sickle cell anemia: a glass half full?","volume":"123","author":"Steinberg","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jmb.2023.168343_b0215","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/ajh.25937","article-title":"Individual red blood cell fetal hemoglobin quantification allows to determine protective thresholds in sickle cell disease","volume":"95","author":"Hebert","year":"2020","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.jmb.2023.168343_b0220","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a011700","article-title":"The molecular basis of beta-thalassemia","volume":"3","author":"Thein","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.jmb.2023.168343_b0225","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bcmd.2017.06.001","article-title":"Molecular basis of beta thalassemia and potential therapeutic targets","volume":"70","author":"Thein","year":"2018","journal-title":"Blood Cell Mol. Dis."},{"key":"10.1016\/j.jmb.2023.168343_b0230","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/35066048","article-title":"Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias","volume":"2","author":"Weatherall","year":"2001","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jmb.2023.168343_b0235","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.tig.2018.09.004","article-title":"Wake-up sleepy gene: reactivating fetal globin for beta-hemoglobinopathies","volume":"34","author":"Wienert","year":"2018","journal-title":"Trends Genet."},{"key":"10.1016\/j.jmb.2023.168343_b0240","article-title":"Manipulation of Developmental Gamma-Globin Gene Expression: an Approach for Healing Hemoglobinopathies","volume":"41","author":"Venkatesan","year":"2020","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jmb.2023.168343_b0245","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1126\/science.1194035","article-title":"Sickle cell disease at 100 years","volume":"329","author":"Orkin","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jmb.2023.168343_b0250","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1182\/blood-2009-07-233528","article-title":"Malaria in patients with sickle cell anemia: burden, risk factors, and outcome at the outpatient clinic and during hospitalization","volume":"115","author":"Makani","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jmb.2023.168343_b0255","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1182\/blood-2010-01-251348","article-title":"The inherited diseases of hemoglobin are an emerging global health burden","volume":"115","author":"Weatherall","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jmb.2023.168343_b0260","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1365-2141.2011.08742.x","article-title":"The challenge of haemoglobinopathies in resource-poor countries","volume":"154","author":"Weatherall","year":"2011","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jmb.2023.168343_b0265","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.hoc.2022.12.012","article-title":"Gene Therapy and Gene Editing for beta-Thalassemia","volume":"37","author":"Christakopoulos","year":"2023","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"10.1016\/j.jmb.2023.168343_b0270","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24119527","article-title":"Precision editing as a therapeutic approach for beta-hemoglobinopathies","volume":"24","author":"Paschoudi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jmb.2023.168343_b0275","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/s41588-023-01434-7","article-title":"Potent and uniform fetal hemoglobin induction via base editing","volume":"55","author":"Mayuranathan","year":"2023","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jmb.2023.168343_b0280","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1182\/bloodadvances.2021006281","article-title":"Lifetime medical costs attributable to sickle cell disease among nonelderly individuals with commercial insurance","volume":"7","author":"Johnson","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.jmb.2023.168343_b0285","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.molcel.2020.11.006","article-title":"ZNF410 uniquely activates the NuRD component CHD4 to silence fetal hemoglobin expression","volume":"81","author":"Lan","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jmb.2023.168343_b0290","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41588-021-00843-w","article-title":"ZNF410 represses fetal globin by singular control of CHD4","volume":"53","author":"Vinjamur","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jmb.2023.168343_b0295","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nrc3091","article-title":"Cancer biology and NuRD: a multifaceted chromatin remodelling complex","volume":"11","author":"Lai","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jmb.2023.168343_b0300","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.stem.2012.04.011","article-title":"NuRD and pluripotency: a complex balancing act","volume":"10","author":"Hu","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jmb.2023.168343_b0305","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.tibs.2022.06.002","article-title":"A NuRD for all seasons","volume":"48","author":"Reid","year":"2023","journal-title":"Trends Biochem. Sci"},{"key":"10.1016\/j.jmb.2023.168343_b0310","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1182\/blood-2012-11-466227","article-title":"Mi2beta-mediated silencing of the fetal gamma-globin gene in adult erythroid cells","volume":"121","author":"Amaya","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jmb.2023.168343_b0315","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/s41588-019-0453-4","article-title":"Rational targeting of a NuRD subcomplex guided by comprehensive in situ mutagenesis","volume":"51","author":"Sher","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jmb.2023.168343_b0320","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.3324\/haematol.2018.210963","article-title":"Disruption of the MBD2-NuRD complex but not MBD3-NuRD induces high level HbF expression in human adult erythroid cells","volume":"104","author":"Yu","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.jmb.2023.168343_b0325","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2302254120","article-title":"MBD2a-NuRD binds to the methylated gamma-globin gene promoter and uniquely forms a complex required for silencing of HbF expression","volume":"120","author":"Shang","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"10.1016\/j.jmb.2023.168343_b0330","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2307287120","article-title":"Analysis of the complex between MBD2 and the histone deacetylase core of NuRD reveals key interactions critical for gene silencing","volume":"120","author":"Leighton","year":"2023","journal-title":"Proc. Natl. Acad. Sci U S A"},{"key":"10.1016\/j.jmb.2023.168343_b0335","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1093\/nar\/gkv168","article-title":"An intrinsically disordered region of methyl-CpG binding domain protein 2 (MBD2) recruits the histone deacetylase core of the NuRD complex","volume":"43","author":"Desai","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmb.2023.168343_b0340","doi-asserted-by":"crossref","first-page":"7487","DOI":"10.1073\/pnas.1015341108","article-title":"p66Alpha-MBD2 coiled-coil interaction and recruitment of Mi-2 are critical for globin gene silencing by the MBD2-NuRD complex","volume":"108","author":"Gnanapragasam","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.jmb.2023.168343_b0345","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1126\/science.aad3312","article-title":"Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin","volume":"351","author":"Masuda","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.jmb.2023.168343_b0350","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1126\/science.1165409","article-title":"Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A","volume":"322","author":"Sankaran","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.jmb.2023.168343_b0355","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/ng.630","article-title":"Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin","volume":"42","author":"Borg","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jmb.2023.168343_b0360","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/s41588-022-01152-6","article-title":"HIC2 controls developmental hemoglobin switching by repressing BCL11A transcription","volume":"54","author":"Huang","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jmb.2023.168343_b0365","first-page":"10","article-title":"3'HS1 CTCF binding site in human beta-globin locus regulates fetal hemoglobin expression","author":"Himadewi","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.jmb.2023.168343_b0370","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/s41422-019-0221-0","article-title":"Structural insights into the recognition of gamma-globin gene promoter by BCL11A","volume":"29","author":"Yang","year":"2019","journal-title":"Cell Res."},{"key":"10.1016\/j.jmb.2023.168343_b0375","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1056\/NEJMoa1103070","article-title":"A functional element necessary for fetal hemoglobin silencing","volume":"365","author":"Sankaran","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jmb.2023.168343_b0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109759","article-title":"Structural basis for human ZBTB7A action at the fetal globin promoter","volume":"36","author":"Yang","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.jmb.2023.168343_b0385","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41588-018-0085-0","article-title":"Natural regulatory mutations elevate the fetal globin gene via disruption of BCL11A or ZBTB7A binding","volume":"50","author":"Martyn","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jmb.2023.168343_b0390","doi-asserted-by":"crossref","first-page":"10635","DOI":"10.1093\/nar\/16.22.10635","article-title":"Distal CCAAT box deletion in the A gamma globin gene of two black adolescents with elevated fetal A gamma globin","volume":"16","author":"Gilman","year":"1988","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmb.2023.168343_b0395","doi-asserted-by":"crossref","first-page":"6681","DOI":"10.1093\/nar\/17.16.6681","article-title":"The deletion of the distal CCAAT box region of the A gamma-globin gene in black HPFH abolishes the binding of the erythroid specific protein NFE3 and of the CCAAT displacement protein","volume":"17","author":"Mantovani","year":"1989","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmb.2023.168343_b0400","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/s41588-021-00904-0","article-title":"Activation of gamma-globin gene expression by GATA1 and NF-Y in hereditary persistence of fetal hemoglobin","volume":"53","author":"Doerfler","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jmb.2023.168343_b0405","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1182\/blood-2018-07-863951","article-title":"A natural regulatory mutation in the proximal promoter elevates fetal globin expression by creating a de novo GATA1 site","volume":"133","author":"Martyn","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jmb.2023.168343_b0410","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1126\/science.8332909","article-title":"NMR structure of a specific DNA complex of Zn-containing DNA binding domain of GATA-1","volume":"261","author":"Omichinski","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.jmb.2023.168343_b0415","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cell.2012.11.047","article-title":"Sequence-specific transcription factor NF-Y displays histone-like DNA binding and H2B-like ubiquitination","volume":"152","author":"Nardini","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2023.168343_b0420","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/338435a0","article-title":"Increased gamma-globin expression in a nondeletion HPFH mediated by an erythroid-specific DNA-binding factor","volume":"338","author":"Martin","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2023.168343_b0425","doi-asserted-by":"crossref","first-page":"7085","DOI":"10.1038\/ncomms8085","article-title":"Editing the genome to introduce a beneficial naturally occurring mutation associated with increased fetal globin","volume":"6","author":"Wienert","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jmb.2023.168343_b0430","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.devcel.2009.09.005","article-title":"LRF is an essential downstream target of GATA1 in erythroid development and regulates BIM-dependent apoptosis","volume":"17","author":"Maeda","year":"2009","journal-title":"Dev. Cell"},{"key":"10.1016\/j.jmb.2023.168343_b0435","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s40246-019-0252-0","article-title":"The multi-faceted functioning portrait of LRF\/ZBTB7A","volume":"13","author":"Constantinou","year":"2019","journal-title":"Hum. Genomics"},{"key":"10.1016\/j.jmb.2023.168343_b0440","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.canlet.2020.04.015","article-title":"Emerging role of ZBTB7A as an oncogenic driver and transcriptional repressor","volume":"483","author":"Gupta","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jmb.2023.168343_b0445","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/nar\/27.5.1251","article-title":"FBI-1, a factor that binds to the HIV-1 inducer of short transcripts (IST), is a POZ domain protein","volume":"27","author":"Morrison","year":"1999","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmb.2023.168343_b0450","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nature03203","article-title":"Role of the proto-oncogene Pokemon in cellular transformation and ARF repression","volume":"433","author":"Maeda","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2023.168343_b0455","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1101\/gad.245910.114","article-title":"ZBTB7A acts as a tumor suppressor through the transcriptional repression of glycolysis","volume":"28","author":"Liu","year":"2014","journal-title":"Genes Dev."},{"key":"10.1016\/j.jmb.2023.168343_b0460","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1128\/MCB.17.7.3786","article-title":"Purification and characterization of FBI-1, a cellular factor that binds to the human immunodeficiency virus type 1 inducer of short transcripts","volume":"17","author":"Pessler","year":"1997","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jmb.2023.168343_b0465","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/sj.onc.1202332","article-title":"Novel BTB\/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3\/BCL-6 oncogene","volume":"18","author":"Davies","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.jmb.2023.168343_b0470","doi-asserted-by":"crossref","first-page":"47081","DOI":"10.1074\/jbc.M405288200","article-title":"Leukemia\/lymphoma-related factor, a POZ domain-containing transcriptional repressor, interacts with histone deacetylase-1 and inhibits cartilage oligomeric matrix protein gene expression and chondrogenesis","volume":"279","author":"Liu","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2023.168343_b0475","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1182\/blood.V94.6.1987","article-title":"Osteoclast-derived zinc finger (OCZF) protein with POZ domain, a possible transcriptional repressor, is involved in osteoclastogenesis","volume":"94","author":"Kukita","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.jmb.2023.168343_b0480","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/ni925","article-title":"Bcl11a is essential for normal lymphoid development","volume":"4","author":"Liu","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jmb.2023.168343_b0485","doi-asserted-by":"crossref","first-page":"e1009835","DOI":"10.1371\/journal.pgen.1009835","article-title":"Pathogenic BCL11A variants provide insights into the mechanisms of human fetal hemoglobin silencing","volume":"17","author":"Shen","year":"2021","journal-title":"PLoS Genet."},{"key":"10.1016\/j.jmb.2023.168343_b0490","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13148-020-00987-2","article-title":"DNA methylation patterns of beta-globin cluster in beta-thalassemia patients","volume":"12","author":"Bao","year":"2020","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.jmb.2023.168343_b0495","doi-asserted-by":"crossref","first-page":"7344","DOI":"10.1074\/jbc.RA118.001785","article-title":"Structural basis for the ability of MBD domains to bind methyl-CG and TG sites in DNA","volume":"293","author":"Liu","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2023.168343_b0500","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.tibs.2012.12.005","article-title":"A common mode of recognition for methylated CpG","volume":"38","author":"Liu","year":"2013","journal-title":"Trends Biochem. Sci"},{"key":"10.1016\/j.jmb.2023.168343_b0505","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/ng.637","article-title":"KLF1 regulates BCL11A expression and gamma- to beta-globin gene switching","volume":"42","author":"Zhou","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jmb.2023.168343_b0510","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1182\/bloodadvances.2016002303","article-title":"KLF1 directly activates expression of the novel fetal globin repressor ZBTB7A\/LRF in erythroid cells","volume":"1","author":"Norton","year":"2017","journal-title":"Blood Adv."},{"key":"10.1016\/j.jmb.2023.168343_b0515","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3324\/haematol.2010.037333","article-title":"Compound heterozygosity for KLF1 mutations associated with remarkable increase of fetal hemoglobin and red cell protoporphyrin","volume":"96","author":"Satta","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.jmb.2023.168343_b0520","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3324\/haematol.2011.043265","article-title":"Erythroid phenotypes associated with KLF1 mutations","volume":"96","author":"Borg","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.jmb.2023.168343_b0525","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s41598-021-04126-6","article-title":"Epigenomic analysis of KLF1 haploinsufficiency in primary human erythroblasts","volume":"12","author":"Heshusius","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jmb.2023.168343_b0530","first-page":"11","article-title":"Identification of novel HPFH-like mutations by CRISPR base editing that elevate the expression of fetal hemoglobin","author":"Ravi","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.jmb.2023.168343_b0535","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1182\/blood-2017-02-767400","article-title":"KLF1 drives the expression of fetal hemoglobin in British HPFH","volume":"130","author":"Wienert","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jmb.2023.168343_b0540","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1182\/blood.2020005301","article-title":"The HRI-regulated transcription factor ATF4 activates BCL11A transcription to silence fetal hemoglobin expression","volume":"135","author":"Huang","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jmb.2023.168343_b0545","unstructured":"Weiss, K., Lachlan, K., (2020). CHD4 Neurodevelopmental Disorder. In: Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, et al., editors. GeneReviews((R)). Seattle (WA)"},{"key":"10.1016\/j.jmb.2023.168343_b0550","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/ajmg.c.31752","article-title":"The NuRD complex and macrocephaly associated neurodevelopmental disorders","volume":"181","author":"Pierson","year":"2019","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"key":"10.1016\/j.jmb.2023.168343_b0555","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1093\/nar\/gkac1274","article-title":"Allosteric autoregulation of DNA binding via a DNA-mimicking protein domain: a biophysical study of ZNF410-DNA interaction using small angle X-ray scattering","volume":"51","author":"Kaur","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmb.2023.168343_b0560","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1007\/s00277-023-05250-1","article-title":"Prevalence and prognostic significance of IKZF1 deletion in paediatric acute lymphoblastic leukemia: A systematic review and meta-analysis","volume":"102","author":"Srinivasan","year":"2023","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.jmb.2023.168343_b0565","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3324\/haematol.2017.185603","article-title":"The many faces of IKZF1 in B-cell precursor acute lymphoblastic leukemia","volume":"103","author":"Marke","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.jmb.2023.168343_b0570","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.3389\/fimmu.2019.01299","article-title":"Ikaros Zinc Finger Transcription Factors: Regulators of Cytokine Signaling Pathways and CD4(+) T Helper Cell Differentiation","volume":"10","author":"Powell","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jmb.2023.168343_b0575","doi-asserted-by":"crossref","first-page":"14443","DOI":"10.1073\/pnas.1105898108","article-title":"Structural basis of simultaneous recruitment of the transcriptional regulators LMO2 and FOG1\/ZFPM1 by the transcription factor GATA1","volume":"108","author":"Wilkinson-White","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.jmb.2023.168343_b0580","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tig.2013.10.001","article-title":"Ldb1 complexes: the new master regulators of erythroid gene transcription","volume":"30","author":"Love","year":"2014","journal-title":"Trends Genet."},{"key":"10.1016\/j.jmb.2023.168343_b0585","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ajhg.2021.03.005","article-title":"Epigenetic inactivation of ERF reactivates gamma-globin expression in beta-thalassemia","volume":"108","author":"Bao","year":"2021","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jmb.2023.168343_b0590","doi-asserted-by":"crossref","first-page":"16026","DOI":"10.1038\/ncomms16026","article-title":"Targeted DNA methylation in vivo using an engineered dCas9-MQ1 fusion protein","volume":"8","author":"Lei","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jmb.2023.168343_b0595","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S1074-7613(00)80034-5","article-title":"Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes","volume":"10","author":"Kim","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.jmb.2023.168343_b0600","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1073\/pnas.96.2.349","article-title":"Tissue-specific and developmental stage-specific DNA binding by a mammalian SWI\/SNF complex associated with human fetal-to-adult globin gene switching","volume":"96","author":"O'Neill","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.jmb.2023.168343_b0605","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1126\/science.1244851","article-title":"Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells","volume":"343","author":"Kronke","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.jmb.2023.168343_b0610","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1126\/science.1244917","article-title":"The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins","volume":"343","author":"Lu","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.jmb.2023.168343_b0615","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nature16979","article-title":"Structural basis of lenalidomide-induced CK1alpha degradation by the CRL4(CRBN) ubiquitin ligase","volume":"532","author":"Petzold","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2023.168343_b0620","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.chembiol.2021.04.009","article-title":"Haven't got a glue: Protein surface variation for the design of molecular glue degraders","volume":"28","author":"Kozicka","year":"2021","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.jmb.2023.168343_b0625","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/s41589-020-0620-z","article-title":"Prospecting for molecular glues","volume":"16","author":"den Besten","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jmb.2023.168343_b0630","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41586-020-2374-x","article-title":"The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K","volume":"585","author":"Slabicki","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2023.168343_b0635","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nature14610","article-title":"Lenalidomide induces ubiquitination and degradation of CK1alpha in del(5q) MDS","volume":"523","author":"Kronke","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2023.168343_b0640","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat0572","article-title":"Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN","volume":"362","author":"Sievers","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jmb.2023.168343_b0645","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1126\/science.add7574","article-title":"Molecular glue CELMoD compounds are regulators of cereblon conformation","volume":"378","author":"Watson","year":"2022","journal-title":"Science"},{"issue":"235\u201347","key":"10.1016\/j.jmb.2023.168343_b0650","first-page":"e12","article-title":"Discovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapy","volume":"30","author":"Bonazzi","year":"2023","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.jmb.2023.168343_b0655","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1039\/D2MD00347C","article-title":"Structural rationalization of GSPT1 and IKZF1 degradation by thalidomide molecular glue derivatives","volume":"14","author":"Nowak","year":"2023","journal-title":"RSC Med Chem."},{"key":"10.1016\/j.jmb.2023.168343_b0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115580","article-title":"Discovery of new Lenalidomide derivatives as potent and selective GSPT1 degraders","volume":"258","author":"Wei","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jmb.2023.168343_b0665","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.115016","article-title":"Design, synthesis and biological evaluation of novel quinazolinone derivatives as CRBN E3 ligase modulators","volume":"247","author":"Liu","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jmb.2023.168343_b0670","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1172\/JCI32322","article-title":"Pomalidomide and lenalidomide regulate erythropoiesis and fetal hemoglobin production in human CD34+ cells","volume":"118","author":"Moutouh-de Parseval","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jmb.2023.168343_b0675","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1182\/blood-2010-11-319137","article-title":"Pomalidomide augments fetal hemoglobin production without the myelosuppressive effects of hydroxyurea in transgenic sickle cell mice","volume":"118","author":"Meiler","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jmb.2023.168343_b0680","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1038\/s41388-022-02340-8","article-title":"Discovery of a dual WDR5 and Ikaros PROTAC degrader as an anti-cancer therapeutic","volume":"41","author":"Li","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.jmb.2023.168343_b0685","doi-asserted-by":"crossref","first-page":"10611","DOI":"10.1021\/acs.jmedchem.2c00807","article-title":"Discovery of a First-in-class degrader for nuclear receptor binding SET domain protein 2 (NSD2) and ikaros\/aiolos","volume":"65","author":"Meng","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmb.2023.168343_b0690","first-page":"4","article-title":"The zinc finger proteins ZNF644 and WIZ regulate the G9a\/GLP complex for gene repression","author":"Bian","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.jmb.2023.168343_b0695","doi-asserted-by":"crossref","first-page":"20120","DOI":"10.1074\/jbc.M603087200","article-title":"Zinc finger protein Wiz links G9a\/GLP histone methyltransferases to the co-repressor molecule CtBP","volume":"281","author":"Ueda","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2023.168343_b0700","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/nar\/gkq081","article-title":"A case study in cross-talk: the histone lysine methyltransferases G9a and GLP","volume":"38","author":"Collins","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmb.2023.168343_b0705","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1101\/gad.2027411","article-title":"H3K9 methyltransferase G9a and the related molecule GLP","volume":"25","author":"Shinkai","year":"2011","journal-title":"Genes Dev."},{"key":"10.1016\/j.jmb.2023.168343_b0710","doi-asserted-by":"crossref","first-page":"e1316888","DOI":"10.1080\/23262133.2017.1316888","article-title":"The expanding role of the Ehmt2\/G9a complex in neurodevelopment","volume":"4","author":"Deimling","year":"2017","journal-title":"Neurogenesis (Austin)."},{"key":"10.1016\/j.jmb.2023.168343_b0715","doi-asserted-by":"crossref","DOI":"10.3390\/epigenomes5040023","article-title":"G9a: an emerging epigenetic target for melanoma therapy","volume":"5","author":"Flesher","year":"2021","journal-title":"Epigenomes"},{"key":"10.1016\/j.jmb.2023.168343_b0720","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/s41580-022-00483-w","article-title":"Establishment of H3K9-methylated heterochromatin and its functions in tissue differentiation and maintenance","volume":"23","author":"Padeken","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jmb.2023.168343_b0725","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1101\/gad.1463706","article-title":"Direct interaction between DNMT1 and G9a coordinates DNA and histone methylation during replication","volume":"20","author":"Esteve","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.jmb.2023.168343_b0730","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1021\/bi100213t","article-title":"Coordinated chromatin control: structural and functional linkage of DNA and histone methylation","volume":"49","author":"Cheng","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmb.2023.168343_b0735","doi-asserted-by":"crossref","first-page":"8086","DOI":"10.1021\/acs.jmedchem.3c00411","article-title":"Structure-based design and characterization of the highly potent and selective covalent inhibitors targeting the lysine methyltransferases G9a\/GLP","volume":"66","author":"Feng","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmb.2023.168343_b0740","doi-asserted-by":"crossref","first-page":"10506","DOI":"10.1021\/acs.jmedchem.2c00652","article-title":"Discovery of the first-in-class G9a\/GLP covalent inhibitors","volume":"65","author":"Park","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmb.2023.168343_b0745","doi-asserted-by":"crossref","first-page":"e22674","DOI":"10.1002\/jbt.22674","article-title":"Targeting H3K9 methyltransferase G9a and its related molecule GLP as a potential therapeutic strategy for cancer","volume":"35","author":"Rahman","year":"2021","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.jmb.2023.168343_b0750","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ejmech.2019.06.072","article-title":"Recent progress in histone methyltransferase (G9a) inhibitors as anticancer agents","volume":"179","author":"Cao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jmb.2023.168343_b0755","doi-asserted-by":"crossref","first-page":"993","DOI":"10.4155\/fmc-2018-0396","article-title":"Insights for the design of protein lysine methyltransferase G9a inhibitors","volume":"11","author":"Charles","year":"2019","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.jmb.2023.168343_b0760","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1021\/acs.jmedchem.8b02008","article-title":"Discovery of a novel chemotype of histone lysine methyltransferase EHMT1\/2 (GLP\/G9a) inhibitors: rational design, synthesis, biological evaluation, and co-crystal structure","volume":"62","author":"Milite","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmb.2023.168343_b0765","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1021\/acs.jmedchem.6b01645","article-title":"Discovery of potent and selective inhibitors for G9a-like protein (GLP) lysine methyltransferase","volume":"60","author":"Xiong","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmb.2023.168343_b0770","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1182\/blood-2015-02-629972","article-title":"Inhibition of G9a methyltransferase stimulates fetal hemoglobin production by facilitating LCR\/gamma-globin looping","volume":"126","author":"Krivega","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jmb.2023.168343_b0775","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1182\/blood-2015-06-649087","article-title":"EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression","volume":"126","author":"Renneville","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jmb.2023.168343_b0780","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1007\/s00277-020-04136-w","article-title":"UNC0638 induces high levels of fetal hemoglobin expression in beta-thalassemia\/HbE erythroid progenitor cells","volume":"99","author":"Nualkaew","year":"2020","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.jmb.2023.168343_b0785","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41467-022-35404-0","article-title":"A specific G9a inhibitor unveils BGLT3 lncRNA as a universal mediator of chemically induced fetal globin gene expression","volume":"14","author":"Takase","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jmb.2023.168343_b0790","doi-asserted-by":"crossref","first-page":"6200","DOI":"10.1182\/blood-2011-06-363101","article-title":"Distinct Ldb1\/NLI complexes orchestrate gamma-globin repression and reactivation through ETO2 in human adult erythroid cells","volume":"118","author":"Kiefer","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jmb.2023.168343_b0795","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23137025","article-title":"LRF promotes indirectly advantageous chromatin conformation via BGLT3-lncRNA expression and switch from fetal to adult hemoglobin","volume":"23","author":"Chondrou","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jmb.2023.168343_b0800","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1182\/blood-2018-07-862003","article-title":"Fetal gamma-globin genes are regulated by the BGLT3 long noncoding RNA locus","volume":"132","author":"Ivaldi","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jmb.2023.168343_b0805","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/0092-8674(92)90561-P","article-title":"A targeting sequence directs DNA methyltransferase to sites of DNA replication in mammalian nuclei","volume":"71","author":"Leonhardt","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2023.168343_b0810","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/0092-8674(92)90611-F","article-title":"Targeted mutation of the DNA methyltransferase gene results in embryonic lethality","volume":"69","author":"Li","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2023.168343_b0815","doi-asserted-by":"crossref","first-page":"33002","DOI":"10.1074\/jbc.274.46.33002","article-title":"Recombinant human DNA (cytosine-5) methyltransferase. I. Expression, purification, and comparison of de novo and maintenance methylation","volume":"274","author":"Pradhan","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2023.168343_b0820","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1093\/nar\/gks155","article-title":"Recognition and potential mechanisms for replication and erasure of cytosine hydroxymethylation","volume":"40","author":"Hashimoto","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmb.2023.168343_b0825","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/0092-8674(80)90086-0","article-title":"DNA methylation in the human gamma delta beta-globin locus in erythroid and nonerythroid tissues","volume":"19","author":"van der Ploeg","year":"1980","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2023.168343_b0830","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1093\/nar\/8.20.4563","article-title":"A novel type of secondary modification of two CCGG residues in the human gamma delta beta-globin gene locus","volume":"8","author":"van der Ploeg","year":"1980","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmb.2023.168343_b0835","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/leu.2008.397","article-title":"The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells","volume":"23","author":"Flotho","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.jmb.2023.168343_b0840","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrd1930","article-title":"Epigenetic therapy of cancer: past, present and future","volume":"5","author":"Yoo","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jmb.2023.168343_b0845","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0092-8674(80)90237-8","article-title":"Cellular differentiation, cytidine analogs and DNA methylation","volume":"20","author":"Jones","year":"1980","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2023.168343_b0850","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/cts.13548","article-title":"DNA methyltransferase inhibitor exposure-response: Challenges and opportunities","volume":"16","author":"Kagan","year":"2023","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.jmb.2023.168343_b0855","doi-asserted-by":"crossref","first-page":"6993","DOI":"10.1073\/pnas.81.22.6993","article-title":"Covalent bond formation between a DNA-cytosine methyltransferase and DNA containing 5-azacytosine","volume":"81","author":"Santi","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.jmb.2023.168343_b0860","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1006\/jmbi.1998.2426","article-title":"Mechanism of inhibition of DNA (cytosine C5)-methyltransferases by oligodeoxyribonucleotides containing 5,6-dihydro-5-azacytosine","volume":"285","author":"Sheikhnejad","year":"1999","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2023.168343_b0865","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13148-019-0776-0","article-title":"The timeline of epigenetic drug discovery: from reality to dreams","volume":"11","author":"Ganesan","year":"2019","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.jmb.2023.168343_b0870","doi-asserted-by":"crossref","first-page":"4428","DOI":"10.1073\/pnas.79.14.4428","article-title":"5-Azacytidine stimulates fetal hemoglobin synthesis in anemic baboons","volume":"79","author":"DeSimone","year":"1982","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.jmb.2023.168343_b0875","first-page":"489","article-title":"Fetal hemoglobin production in adult baboons by 5-azacytidine or by phenylhydrazine-induced hemolysis is associated with hypomethylation of globin gene DNA","volume":"134","author":"DeSimone","year":"1983","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/j.jmb.2023.168343_b0880","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1056\/NEJM198212093072401","article-title":"5-azacytidine selectively increases gamma-globin synthesis in a patient with beta+ thalassemia","volume":"307","author":"Ley","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jmb.2023.168343_b0885","first-page":"457","article-title":"DNA methylation and globin gene expression in patients treated with 5-azacytidine","volume":"134","author":"Ley","year":"1983","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/j.jmb.2023.168343_b0890","first-page":"475","article-title":"5-Azacytidine increases fetal hemoglobin production in a patient with sickle cell disease","volume":"134","author":"Dover","year":"1983","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/j.jmb.2023.168343_b0895","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM199309163291205","article-title":"Brief report: treatment with azacitidine of patients with end-stage beta-thalassemia","volume":"329","author":"Lowrey","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jmb.2023.168343_b0900","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1182\/blood-2003-05-1738","article-title":"Effects of 5-aza-2'-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease","volume":"102","author":"Saunthararajah","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jmb.2023.168343_b0905","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.exphem.2010.08.001","article-title":"Decitabine increases fetal hemoglobin in Papio anubis by increasing gamma-globin gene transcription","volume":"38","author":"Akpan","year":"2010","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.jmb.2023.168343_b0910","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.str.2022.03.009","article-title":"Structural characterization of dicyanopyridine containing DNMT1-selective, non-nucleoside inhibitors","volume":"30","author":"Horton","year":"2022","journal-title":"Structure"},{"key":"10.1016\/j.jmb.2023.168343_b0915","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/s43018-021-00249-x","article-title":"Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia","volume":"2","author":"Pappalardi","year":"2021","journal-title":"Nat Cancer."},{"key":"10.1016\/j.jmb.2023.168343_b0920","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.3324\/haematol.2020.248658","article-title":"In vitro and in vivo induction of fetal hemoglobin with a reversible and selective DNMT1 inhibitor","volume":"106","author":"Gilmartin","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.jmb.2023.168343_b0925","doi-asserted-by":"crossref","first-page":"zcad022","DOI":"10.1093\/narcan\/zcad022","article-title":"GSK-3484862 targets DNMT1 for degradation in cells","volume":"5","author":"Chen","year":"2023","journal-title":"NAR Cancer"},{"key":"10.1016\/j.jmb.2023.168343_b0930","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2009.06.001","article-title":"CTCF: master weaver of the genome","volume":"137","author":"Phillips","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2023.168343_b0935","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1139\/o11-040","article-title":"The role of CTCF in coordinating the expression of single gene loci","volume":"89","author":"Gillen","year":"2011","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.jmb.2023.168343_b0940","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrg3663","article-title":"CTCF: an architectural protein bridging genome topology and function","volume":"15","author":"Ong","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jmb.2023.168343_b0945","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/s41576-018-0060-8","article-title":"Organizational principles of 3D genome architecture","volume":"19","author":"Rowley","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jmb.2023.168343_b0950","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1749-6632.1998.tb10460.x","article-title":"Molecular basis of hereditary persistence of fetal hemoglobin","volume":"850","author":"Forget","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jmb.2023.168343_b0955","doi-asserted-by":"crossref","first-page":"10661","DOI":"10.1073\/pnas.1612075113","article-title":"Genome editing using CRISPR-Cas9 to create the HPFH genotype in HSPCs: An approach for treating sickle cell disease and beta-thalassemia","volume":"113","author":"Ye","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.jmb.2023.168343_b0960","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.cell.2015.07.038","article-title":"CRISPR inversion of CTCF sites alters genome topology and enhancer\/promoter function","volume":"162","author":"Guo","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2023.168343_b0965","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0378-1119(00)00140-2","article-title":"Roles of the NFI\/CTF gene family in transcription and development","volume":"249","author":"Gronostajski","year":"2000","journal-title":"Gene"},{"key":"10.1016\/j.jmb.2023.168343_b0970","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/hmg\/ddy051","article-title":"14q32 and let-7 microRNAs regulate transcriptional networks in fetal and adult human erythroblasts","volume":"27","author":"Lessard","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jmb.2023.168343_b0975","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/s41588-022-01076-1","article-title":"Dual function NFI factors control fetal hemoglobin silencing in adult erythroid cells","volume":"54","author":"Qin","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jmb.2023.168343_b0980","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1182\/blood-2005-09-008656","article-title":"E2f4 regulates fetal erythropoiesis through the promotion of cellular proliferation","volume":"108","author":"Kinross","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jmb.2023.168343_b0985","doi-asserted-by":"crossref","first-page":"20966","DOI":"10.1074\/jbc.M109.006346","article-title":"EKLF\/KLF1 controls cell cycle entry via direct regulation of E2f2","volume":"284","author":"Tallack","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2023.168343_b0990","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4161\/cc.9.2.10467","article-title":"pRB and E2F4 play distinct cell-intrinsic roles in fetal erythropoiesis","volume":"9","author":"Zhang","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jmb.2023.168343_b0995","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1182\/blood.2021011044","article-title":"Molecular and cellular mechanisms that regulate human erythropoiesis","volume":"139","author":"Caulier","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jmb.2023.168343_b1000","doi-asserted-by":"crossref","first-page":"P809","DOI":"10.1016\/S0140-6736(05)78941-8","article-title":"US FDA approves first drug for sickle-cell anaemia","volume":"351","author":"Ault","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jmb.2023.168343_b1005","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMct0708272","article-title":"Hydroxyurea for the treatment of sickle cell anemia","volume":"358","author":"Platt","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jmb.2023.168343_b1010","doi-asserted-by":"crossref","first-page":"e584","DOI":"10.1097\/HS9.0000000000000584","article-title":"Research in sickle cell disease: from bedside to bench to bedside","volume":"5","author":"Salinas Cisneros","year":"2021","journal-title":"Hemasphere."},{"key":"10.1016\/j.jmb.2023.168343_b1015","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40246-018-0177-z","article-title":"Impact of ZBTB7A hypomethylation and expression patterns on treatment response to hydroxyurea","volume":"12","author":"Chondrou","year":"2018","journal-title":"Hum. Genomics"},{"key":"10.1016\/j.jmb.2023.168343_b1020","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1128\/MCB.16.7.3814","article-title":"MEF2B is a potent transactivator expressed in early myogenic lineages","volume":"16","author":"Molkentin","year":"1996","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jmb.2023.168343_b1025","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/ni.2688","article-title":"MEF2B mutations lead to deregulated expression of the oncogene BCL6 in diffuse large B cell lymphoma","volume":"14","author":"Ying","year":"2013","journal-title":"Nat. Immunol."},{"issue":"453\u201365","key":"10.1016\/j.jmb.2023.168343_b1030","first-page":"e9","article-title":"MEF2B instructs germinal center development and acts as an oncogene in B cell lymphomagenesis","volume":"34","author":"Brescia","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jmb.2023.168343_b1035","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-1-62703-646-7_5","article-title":"BLAST and FASTA similarity searching for multiple sequence alignment","volume":"1079","author":"Pearson","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jmb.2023.168343_b1040","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3390\/ph15060753","article-title":"Pharmacological induction of fetal hemoglobin in beta-thalassemia and sickle cell disease: an updated perspective","volume":"15","author":"Bou-Fakhredin","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jmb.2023.168343_b1045","doi-asserted-by":"crossref","first-page":"12617","DOI":"10.1073\/pnas.1006774107","article-title":"Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease","volume":"107","author":"Bradner","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.jmb.2023.168343_b1050","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1182\/blood-2015-02-626259","article-title":"The LSD1 inhibitor RN-1 induces fetal hemoglobin synthesis and reduces disease pathology in sickle cell mice","volume":"126","author":"Cui","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jmb.2023.168343_b1055","doi-asserted-by":"crossref","DOI":"10.1097\/01.HS9.0000848848.73193.ff","article-title":"P1498: inhibition of polycomb repressive complex 2 through EED induces fetal hemoglobin in healthy and sickle cell disease models","volume":"6","author":"Stuart","year":"2022","journal-title":"HemaSphere."},{"key":"10.1016\/j.jmb.2023.168343_b1060","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2023.102334","article-title":"Recent advances in the development of peptide-based inhibitors targeting epigenetic readers of histone lysine acetylation and methylation marks","volume":"75","author":"Liu","year":"2023","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.jmb.2023.168343_b1065","doi-asserted-by":"crossref","first-page":"8902","DOI":"10.1021\/jacs.1c03852","article-title":"TF-PROTACs enable targeted degradation of transcription factors","volume":"143","author":"Liu","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jmb.2023.168343_b1070","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1021\/acsmedchemlett.3c00126","article-title":"Development of DNA aptamer-based PROTACs that degrade the estrogen receptor","volume":"14","author":"Tsujimura","year":"2023","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.jmb.2023.168343_b1075","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkad594","article-title":"Structures of CTCF-DNA complexes including all 11 zinc fingers","author":"Yang","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmb.2023.168343_b1080","doi-asserted-by":"crossref","first-page":"D794","DOI":"10.1093\/nar\/gkx1081","article-title":"The encyclopedia of DNA elements (ENCODE): data portal update","volume":"46","author":"Davis","year":"2018","journal-title":"Nucleic Acids Res."}],"container-title":["Journal of Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283623004540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283623004540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T01:34:52Z","timestamp":1729042492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022283623004540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":216,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0022283623004540"],"URL":"https:\/\/doi.org\/10.1016\/j.jmb.2023.168343","relation":{},"ISSN":["0022-2836"],"issn-type":[{"value":"0022-2836","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"C2H2 Zinc Finger Transcription Factors Associated with Hemoglobinopathies","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmb.2023.168343","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"168343"}}